Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1966 1
1996 4
1997 2
1998 2
1999 5
2000 2
2001 5
2002 4
2003 1
2004 3
2005 3
2006 6
2007 5
2008 7
2009 7
2010 4
2011 10
2012 6
2013 5
2014 6
2015 5
2016 1
2017 3
2018 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 16970136

92 results
Results by year
Filters applied: . Clear all
Page 1
Newer antibiotics for serious gram-positive infections.
Fraser TG, Hansen C, Long JK. Fraser TG, et al. Cleve Clin J Med. 2006 Sep;73(9):847-53. doi: 10.3949/ccjm.73.9.847. Cleve Clin J Med. 2006. PMID: 16970136 Free article. Review.
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Lundstrom TS, Sobel JD. Lundstrom TS, et al. Infect Dis Clin North Am. 2004 Sep;18(3):651-68, x. doi: 10.1016/j.idc.2004.04.014. Infect Dis Clin North Am. 2004. PMID: 15308280 Review.
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
Nailor MD, Sobel JD. Nailor MD, et al. Infect Dis Clin North Am. 2009 Dec;23(4):965-82, ix. doi: 10.1016/j.idc.2009.06.010. Infect Dis Clin North Am. 2009. PMID: 19909893 Review.
[New anti-Gram+antibiotics: which role in infective endocarditis?].
Makinson A, Le Moing V. Makinson A, et al. Ann Cardiol Angeiol (Paris). 2008 Apr;57(2):88-92. doi: 10.1016/j.ancard.2008.02.008. Epub 2008 Mar 17. Ann Cardiol Angeiol (Paris). 2008. PMID: 18395180 Review. French.
Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
Tush GM, Huneycutt S, Phillips A, Ward JD. Tush GM, et al. Clin Infect Dis. 1998 Jun;26(6):1460-1. doi: 10.1086/517663. Clin Infect Dis. 1998. PMID: 9636880 No abstract available.
[Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Garnacho-Montero J, Amaya-Villar R, Gómez-Grande ML, Jerez V, Lorente-Ramos L, Loza A, Martínez A, Pozo JC, Sierra R, Pomares J, de la Torre MV, Ortiz C. Garnacho-Montero J, et al. Rev Esp Quimioter. 2011 Mar;24(1):13-24. Rev Esp Quimioter. 2011. PMID: 21412665 Free article. Review. Spanish.
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Tan TY, Pitman I, Penrose-Stevens A, Simpson BA, Flanagan PG. Tan TY, et al. J Infect. 2000 Jul;41(1):95-7. doi: 10.1053/jinf.2000.0665. J Infect. 2000. PMID: 11041712
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Group.
Nichols RL, Graham DR, Barriere SL, Rodgers A, Wilson SE, Zervos M, Dunn DL, Kreter B. Nichols RL, et al. J Antimicrob Chemother. 1999 Aug;44(2):263-73. doi: 10.1093/jac/44.2.263. J Antimicrob Chemother. 1999. PMID: 10473234 Clinical Trial.
Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Jenkins I. Jenkins I. J Hosp Med. 2007 Sep;2(5):343-4. doi: 10.1002/jhm.236. J Hosp Med. 2007. PMID: 17935250 No abstract available.
Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
Munoz-Price LS, Lolans K, Quinn JP. Munoz-Price LS, et al. Clin Infect Dis. 2005 Aug 15;41(4):565-6. doi: 10.1086/432121. Clin Infect Dis. 2005. PMID: 16028170 No abstract available.
92 results
Jump to page